About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

For more information on Bionano’s OGM solutions, visit www.bionano.com.

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

Pimple patches seem to be soaring in popularity—and a newly invented type that makes zits disappear without pain or irrtitation in mere days could soon be all the rage. Researchers have created a ...

Smylie and Charlie discuss how J.J. Spaun's new chipping technique highlights his high skill and confidence, shaping his strong performance on the greens. Judge says Greenpeace must pay $345 million ...

Objective: Translation of fertility risks through whole-exome sequencing of family lines to identify variants that explain patient’s clinical phenotypes. Methods: 1. Using techniques such as amniotic ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...